NeoGenomics (NEO) said Tuesday that it has promoted chief commercial officer Warren Stone to president and chief operating officer, effective April 1.
Stone will succeed COO Melody Harris, who will depart at the end of May, the cancer diagnostics company said. Stone will retain his chief commercial officer role, it added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.